Meredith Manning insider trades

Open-market stock purchases and sales by Meredith Manning, Chief Commercial Officer at Soleno Therapeutics Inc, from SEC Form 4 filings since Sep 17, 2018.

Recent trades

DateStockTradeValue
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)—
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$1.4M
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$4.2M
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$1.4M
Mar 27, 2026SLNO Soleno Therapeutics IncSold$146K
Mar 27, 2026SLNO Soleno Therapeutics IncSold$65.2K
Mar 27, 2026SLNO Soleno Therapeutics IncSold$17.7K
Jan 21, 2026SLNO Soleno Therapeutics IncBought (not open market)—
Jan 21, 2026SLNO Soleno Therapeutics IncBought (not open market)—
Dec 15, 2025SLNO Soleno Therapeutics IncSold (not open market)$96K

Companies traded

  • SLNO Soleno Therapeutics Inc: 12 sales, last May 18, 2026
  • TORC resTORbio, Inc: other filings, last Sep 17, 2018

Get free alerts when Meredith Manning files a new trade →